This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kelling, J. Articles by Jordan, M. A. Search for Related Content PubMed PubMed Citation Articles by Kelling, J. Articles by Jordan, M. A.

Suppression of Centromere Dynamics by Taxol® in Living Osteosarcoma Cells¹

Department of Molecular, Cellular, and Developmental Biology and the Neuroscience Research Institute, University of California Santa Barbara, Santa Barbara, California 93106 [J. K., L. W., M. A. J.], and Department of Cell Biology, Scripps Research Institute, La Jolla, California 92037 [K. S.]

Taxol® potently blocks mitosis at the transition from metaphase to anaphase, leading to apoptosis in many types of tumor cells. However, the precise mechanism of action of Taxol® is not understood. Here we have tested the hypothesis that a primary mechanism of action of Taxol® involves suppression of spindle microtubule dynamics. We have used centromere-binding protein B coupled to green fluorescent protein as a marker for the kinetochores and centromeres of chromosomes and analyzed the effects of low Taxol® concentrations on the dynamics of centromeres during metaphase of mitosis in living human osteosarcoma (U2OS) cells by quantitative time-lapse confocal microscopy. In the absence of Taxol®, the centromere pairs on attached sister chromatids alternately stretch apart and relax back together approximately 1.2 times/min due to tension on the kinetochores produced by the spindle microtubules (referred to here as centromere dynamics). We found that 50–100 nM Taxol® significantly suppressed centromere dynamics. For example, Taxol® reduced the mean separation distance between the sister centromeres from 0.73 to 0.65 µm, a distance equivalent to that observed in the complete absence of microtubules. The frequency of transitions between stretching and relaxing was also significantly diminished by Taxol® (by 27%–35%). The suppressive effects of Taxol® on centromere dynamics were associated with maximal accumulation of cells at mitosis (63%), a >90% block of the metaphase/anaphase transition, and complete inhibition of cell proliferation. The data strongly support the idea that the inhibition of centromere dynamics by Taxol® prevents silencing of the mitotic spindle surveillance (checkpoint) mechanism. Because Taxol® strongly suppresses microtubule dynamics, the data also indicate that centromere dynamics can be accounted for by microtubule dynamics and may not require significant energetic contributions from microtubule motors. The strict correlation between the degree of suppression of centromere dynamics by Taxol® and the degree of mitotic block strongly indicates that the primary mechanism responsible for the mitotic block by Taxol® in U2OS cells involves suppression of the polymerization dynamics of kinetochore microtubules.

This article has been cited by other articles:

				T. Okouneva, O. Azarenko, L. Wilson, B. A. Littlefield, and M. A. Jordan Inhibition of centromere dynamics by eribulin (E7389) during mitotic metaphase Mol. Cancer Ther., July 1, 2008; 7(7): 2003 - 2011. [Abstract] [Full Text] [PDF]

				S.-F. Lin, S. P. Gao, D. L. Price, S. Li, T.-C. Chou, P. Singh, Y.-Y. Huang, Y. Fong, and R. J. Wong Synergy of a Herpes Oncolytic Virus and Paclitaxel for Anaplastic Thyroid Cancer Clin. Cancer Res., March 1, 2008; 14(5): 1519 - 1528. [Abstract] [Full Text] [PDF]

				F. Gasparri, P. Cappella, and A. Galvani Multiparametric Cell Cycle Analysis by Automated Microscopy J Biomol Screen, September 1, 2006; 11(6): 586 - 598. [Abstract] [PDF]

				A.-J. Dijkhuis, K. Klappe, S. Jacobs, B.-J. Kroesen, W. Kamps, H. Sietsma, and J. W. Kok PDMP sensitizes neuroblastoma to paclitaxel by inducing aberrant cell cycle progression leading to hyperploidy. Mol. Cancer Ther., March 1, 2006; 5(3): 593 - 601. [Abstract] [Full Text] [PDF]

				M. A. Jordan, K. Kamath, T. Manna, T. Okouneva, H. P. Miller, C. Davis, B. A. Littlefield, and L. Wilson The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growth Mol. Cancer Ther., July 1, 2005; 4(7): 1086 - 1095. [Abstract] [Full Text] [PDF]

				Z. Chen, P. J. Merta, N.-H. Lin, S. K. Tahir, P. Kovar, H. L. Sham, and H. Zhang A-432411, a novel indolinone compound that disrupts spindle pole formation and inhibits human cancer cell growth Mol. Cancer Ther., April 1, 2005; 4(4): 562 - 568. [Abstract] [Full Text] [PDF]

				E. A. Lee, M. K. Keutmann, M. L. Dowling, E. Harris, G. Chan, and G. D. Kao Inactivation of the mitotic checkpoint as a determinant of the efficacy of microtubule-targeted drugs in killing human cancer cells Mol. Cancer Ther., June 1, 2004; 3(6): 661 - 669. [Abstract] [Full Text] [PDF]

				S. Honore, K. Kamath, D. Braguer, L. Wilson, C. Briand, and M. A. Jordan Suppression of microtubule dynamics by discodermolide by a novel mechanism is associated with mitotic arrest and inhibition of tumor cell proliferation Mol. Cancer Ther., December 1, 2003; 2(12): 1303 - 1311. [Abstract] [Full Text] [PDF]